Designed to target skin cancer, the implantable vaccine opens a door to treating many cancers and inflammatory diseases
A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.
The effort is the fruit of a new model of translational research being pursued at the Wyss Institute for Biologically Inspired Engineering at Harvard University that integrates the latest cancer research with bioinspired technology development. It was led by Wyss Core Faculty member David J. Mooney, Ph.D., who is also the Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences (SEAS), and Wyss Institute Associate Faculty member Glenn Dranoff, M.D., who is co-leader of Dana-Farber Cancer Institute’s Cancer Vaccine Center.
Most therapeutic cancer vaccines available today require doctors to first remove the patient’s immune cells from the body, then reprogram them and reintroduce them back into the body. The new approach, which was first reported to eliminate tumors in mice in Science Translational Medicine in 2009, the year the Wyss Institute was launched, instead uses a small disk-like sponge about the size of a fingernail that is made from FDA-approved polymers. The sponge is implanted under the skin, and is designed to recruit and reprogram a patient’s own immune cells “on site,” instructing them to travel through the body, home in on cancer cells, then kill them.
The technology was initially designed to target cancerous melanoma in skin, but might have application to other cancers. In the preclinical study reported in Science Translational Medicine, 50 percent of mice treated with two doses of the vaccine — mice that would have otherwise died from melanoma within about 25 days — showed complete tumor regression.
“Our vaccine was made possible by combining a wide range of biomedical expertise that thrives in Boston and Cambridge,” said Mooney, who specializes in the design of biomaterials for tissue engineering and drug delivery. “It reflects the bioinspired engineering savvy and technology development focus of engineers and scientists at the Wyss Institute and Harvard SEAS, as well as the immunological and clinical expertise of the researchers and clinicians at Dana-Farber and Harvard Medical School.”
“This is expected to be the first of many new innovative therapies made possible by the Wyss Institute’s collaborative model of translational research that will enter human clinical trials,” said Wyss Founding Director Don Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children’s Hospital, and a Professor of Bioengineering at Harvard SEAS. “It validates our approach, which strives to move technologies into the clinical space much faster than would be possible in a traditional academic environment. It’s enormously gratifying to see one of our first technologies take this giant leap forward.”
The Wyss Institute comprises a consortium of researchers, engineers, clinicians, and staff with industrial and business development experience from the Wyss Institute and nine other collaborating institutions in Greater Boston.
“It is rare to get a new technology tested in the laboratory and moved into human clinical trials so quickly,” said Dranoff, who is also a Professor of Medicine at Harvard Medical School, and Leader of the Dana-Farber/Harvard Cancer Center Program in Cancer Immunology. “We’re beyond thrilled with the momentum, and excited about its potential.”
The Latest Bing News on:
- Trump Administration Selects Five Coronavirus Vaccine Candidates as Finalistson June 3, 2020 at 10:16 am
The White House is eager to project progress, but the public-private partnership it has created still faces scientific hurdles, internal tensions and questions from Congress.
- Nascent Biotech’s CEO Provides Corporate Updates on Phase I Brain Cancer Trial and COVID-19 Development Initiative on SNN Networkon June 3, 2020 at 5:00 am
SAN DIEGO, CA / ACCESSWIRE / June 3, 2020 / Nascent Biotech, Inc (OTCQB:NBIO) (the “Company” or “Nascent”) is pleased to provide a corporate update and summary with a recent interview the Company’s ...
- Vaccines Market Development Trends, Key Manufacturers and Competitive Analysis 2019-2030on June 3, 2020 at 3:08 am
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. Vaccination ...
- Cervical cancer vaccine boost increases supply for up to 84 million girls worldwideon June 3, 2020 at 1:23 am
At least 84 million girls living in some of the world’s poorest countries will now have access to a vaccine which prevents cervical cancer after five drug manufacturers committed to boost global ...
- Sanofi's CEO On Cancer Research, Coronavirus Vaccine Progresson June 3, 2020 at 1:17 am
Despite a global pandemic, Sanofi SA (NASDAQ: SNY) is able to continue its research and development -- and it is "essential" to continue showing success in trials, CEO Paul Hudson said on CNBC's ...
- Sanofi CEO Paul Hudson on cancer research, Covid-19 vaccine and moreon June 2, 2020 at 4:47 pm
Sanofi CEO Paul Hudson joins "Squawk Box" to discuss the company's latest efforts in cancer research, the battle against Covid-19, selling the company's stake in Regeneron and more.
- Global Vaccine Adjuvants Market 2020-2024 | Increase in Awareness About Immunization Programs to Boost Growth | Technavioon June 2, 2020 at 3:45 pm
Technavio has announced its latest market research report titled Global Vaccine Adjuvants Market 2020-2024 (Graphic: Business Wire) LONDON-- ( BUSINESS WIRE )--Technavio has been monitoring the global ...
- EU Eyes Overhaul of Pharma Rules to Tackle Vaccine, Antibiotic Shortageson June 2, 2020 at 8:20 am
The move comes as the European Union continues to fight the COVID-19 pandemic, an effort that has exposed some healthcare shortcomings and the bloc's dependence on foreign supplies of essential drugs ...
- Pharmalittle: Fauci ‘didn’t like’ Moderna vaccine data release; Pfizer breast cancer drug suffers a setbackon June 1, 2020 at 6:42 am
Eli Lilly began the first study of an experimental drug derived from a blood sample of an early U.S. survivor of Covid-19.
- Cervical Cancer Vaccine Market Key Insights and Industry Outlook 2020 to 2026on May 26, 2020 at 6:15 am
New Jersey, United States, - The report is a brilliant presentation of critical dynamics, regional growth, competition, and other important aspects of the Cervical Cancer Vaccine Market. The factual, ...
The Latest Google Headlines on:
The Latest Bing News on:
Fix the internet
- SpaceX is launching its latest batch of internet satellites, including one with a visoron June 3, 2020 at 2:37 pm
Once this mission takes off, SpaceX will have launched a little more than 480 of its Starlink satellites into orbit. That’s only a small fraction of the nearly 12,000 Starlink satellites that the ...
- The most common Roku problems and how to fix themon June 3, 2020 at 1:08 pm
Got a Roku device but it's giving you problems? We've got you covered. We explain how to fix the most common Roku issues in minutes -- no tech support needed.
- Google accused in $5 billion class action lawsuit of tracking ‘private’ internet useon June 3, 2020 at 9:00 am
According to a report published by Reuters, Google is hit with a class action lawsuit that claims that the search giant illegally collecting information about users’ online activity even though they ...
- Exclusive: Internet pioneer Leonard Kleinrock on the great experiment we’re living through, and why the Internet probably won’t breakon June 3, 2020 at 6:24 am
Leonard Kleinrock helped create the Internet. In an interview via Zoom, he reflected on the experiment of a world living more and more inside the Internet during lockdown, why the Internet probably ...
- Mayor Peeples thanks supervisors for repair helpon June 3, 2020 at 6:15 am
Pontotoc City Mayor Bob Peeples thanked the Country Board of supervisors for their help with the recent repair at the Hansberger Sprotsplex.
- Something in the airon June 3, 2020 at 6:10 am
Naveed Qureshi always knew his job was important, but as a telecoms engineer working in East London, it didn’t always feel that way. He spent each week patrolling his patch of the city, riding out in ...
- Fix the homefront before worrying about abroadon June 1, 2020 at 10:55 am
It’s downright impossible not to watch the last two nights of nationwide protest, rioting, and looting and not feel an overburdened sense of dread. The United States, what President Ronald Reagan once ...
- Sing Duets Over the Interneton May 30, 2020 at 10:10 pm
For example, currently gaining traction on Instagram are the trans-Atlantic Lockdown Duets videos that pair Broadway and West End performers. The series was hatched by Alistair Brammer, who played the ...
- How this Seattle man became ‘the internet’s dad’on May 29, 2020 at 9:00 pm
His fatherly advice, punctuated with the occasional corny “dad joke,” includes the acronym SELF, which stands for serve, exercise and eat right, learn and forgive. Forgiveness is important to him ...
- The facts about Section 230, the internet speech law Trump wants to changeon May 28, 2020 at 5:20 pm
President Donald Trump signed an executive order targeting social media companies such as Twitter. The order centers on Section 230, a fragment of law from the 1990s that underpins much of today's ...